Evolus, Inc. (EOLS) Social Stream
EVOLUS INC (EOLS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EOLS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-13 | 7 | $20 | $7 | $15.142 | $10.64 | 42.31% |
| 2022-01-27 | 6 | $20 | $7 | $15.142 | $10.64 | 42.31% |
| 2022-03-04 | 7 | $20 | $7 | $15.142 | $10.64 | 42.31% |
| 2022-04-21 | 7 | $20 | $7 | $15.428 | $10.64 | 45% |
| 2022-04-28 | 7 | $20 | $8 | $15.666 | $10.64 | 47.24% |
| 2022-05-11 | 6 | $20 | $8 | $16 | $10.64 | 50.38% |
| 2022-05-12 | 6 | $20 | $10 | $16.333 | $10.64 | 53.51% |
| 2022-10-13 | 7 | $20 | $10 | $16.571 | $10.64 | 55.74% |
| 2022-11-02 | 5 | $20 | $10 | $16.428 | $10.64 | 54.4% |
| 2022-11-09 | 7 | $20 | $10 | $16.428 | $10.64 | 54.4% |
| 2023-03-09 | 7 | $20 | $10 | $16.714 | $10.64 | 57.09% |
| 2023-05-09 | 8 | $20 | $10 | $16.75 | $10.64 | 57.42% |
| 2023-05-10 | 8 | $25 | $14 | $19.142 | $10.64 | 79.91% |
| 2023-05-26 | 7 | $25 | $16 | $19.714 | $10.64 | 85.28% |
| 2023-06-08 | 7 | $25 | $16 | $20.142 | $10.64 | 89.3% |
| 2023-07-23 | 6 | $25 | $16 | $20.5 | $10.64 | 92.67% |
| 2023-08-03 | 6 | $27 | $20 | $22.333 | $10.64 | 109.9% |
| 2023-11-08 | 4 | $27 | $20 | $23.5 | $10.64 | 120.86% |
The Trend in the Analyst Price Target
Over the past 33 months, EOLS's average price target has gone up $10.69.
EOLS reports an average of 131.1% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-09 | 8 | 20 | 10 | 16.750 | 9.07 | 84.67% |
| 2023-05-26 | 7 | 25 | 16 | 19.714 | 8.78 | 124.53% |
| 2023-06-08 | 6 | 25 | 16 | 20.500 | 8.58 | 138.93% |
| 2023-06-08 | 7 | 25 | 16 | 20.500 | 8.58 | 138.93% |
| 2023-07-23 | 6 | 25 | 16 | 20.500 | 7.41 | 176.65% |
EOLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 3 | 1 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
EOLS's average broker recommendation rating worsened by 0.06 over the prior 26 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, EVOLUS INC's average analyst price target is greater than 563.53% of them.
- In terms of how EVOLUS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1811.77% of that group.
- EOLS has a lower variance in analysts' estimates than -1488.24% of all US stocks.
- In the context of all US stocks, EVOLUS INC's number of analysts covering the stock is higher than 751.32% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to EVOLUS INC are ACET, KZIA, and VYNE.
View All Top Stocks by Price Target
Is EOLS a Buy, Hold or Sell? See the POWR Ratings now!